We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Ways to Generate Embryonic Stem Cells

By Biotechdaily staff writers
Posted on 23 Oct 2005
Scientists have developed two new methods to generate embryonic stem cells (ESCs) in mice that may quell the objections of those who claim that stem cell research necessitates the destruction of human life. More...
Both methods were described in the October 16, 2005, online edition of Nature.

One method, called altered nuclear transfer (ANT), was developed by scientists at the Massachusetts Institute of Technology and the Whitehead Institute for Biomedical Research (MIT, Cambridge, MA, USA) as an ethical alternative to somatic cell nuclear transfer (SCNT), or therapeutic cloning. This method is similar to SCNT but before the donor nucleus is transferred into the egg cell, its DNA is altered so that the resulting blastocyst has no chance of becoming a viable embryo or human being.

The scientists used RNA interference (RNAi) to shut off a gene called Cdxx2, which enables an embryo to grow a placenta. Once the stem cells had been extracted from the blastocysts, the siRNA molecule was deleted by transferring a plasmid into each cell. Stem cells resulting from this procedure proved to be just as robust and versatile as stem cells procured in the traditional way.

"Our work is the first proof-of-principle study to show that altered nuclear transfer not only works but is extremely efficient,” said lead author Rudolf Jaenisch, professor of biology at MIT.

The second method was developed by researchers at Advanced Cell Technology, Inc. (ATC, Worcester, MA, USA). They used a method of deriving stem cells in mice using a single-cell embryo biopsy similar to a method used in preimplantation genetic diagnosis. This technique does not interfere with the developmental potential of embryos. After implantation into a mouse womb, the embryo survived and developed into a baby mouse. The researchers say this method could be used with human embryos.

"In the past, stem cell lines have been isolated from the inner cell mass of blastocysts and in a few instances, from earlier, cleavage-stage embryos,” noted first autor Young Chung, senior scientist at ATC. "We generated five embryonic stem (ES) cells and seven trophoblast stem (TS) cell lines from single mouse embryo cells. The stem cells were able to generate all the cell types of the body, including nerve cells, bone, and beating heart.”





Related Links:
Whitehead Inst./MIT
Advanced Cell Technology, Inc.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.